These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17968795)

  • 1. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
    Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
    Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
    Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
    Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.
    Perme T; Mali S; Vidmar I; Gvardijančič D; Blumauer R; Mishaly D; Grabnar I; Nemec G; Grosek S
    Ups J Med Sci; 2013 May; 118(2):138-42. PubMed ID: 23521358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration.
    Babyn P; Peled N; Manson D; Dagan O; Silver MM; Koren G
    Pediatr Radiol; 1995; 25(1):41-3; discussion 44. PubMed ID: 7761161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
    Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
    N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin-induced foveolar hyperplasia simulating pyloric stenosis in an infant with cyanotic heart disease.
    Mercado-Deane MG; Burton EM; Brawley AV; Hatley R
    Pediatr Radiol; 1994; 24(1):45-6. PubMed ID: 8008495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute gastric outlet obstruction following the administration of prostaglandin: an additional case.
    Kobayashi N; Aida N; Nishimura G; Kashimura T; Ohta M; Kawataki M
    Pediatr Radiol; 1997 Jan; 27(1):57-9. PubMed ID: 8995170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of hypertrophic pyloric stenosis in a patient with prostaglandin-induced foveolar hyperplasia.
    Callahan MJ; McCauley RG; Patel H; Hijazi ZM
    Pediatr Radiol; 1999 Oct; 29(10):748-51. PubMed ID: 10525782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
    Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
    Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
    Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
    Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
    Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
    Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
    Reddy SC; Saxena A
    Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal transport issues with prostaglandin E1 infusions.
    Grubbs TC; Kraft NL
    Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient hypertrophic pyloric stenosis due to prostoglandin infusion.
    Soyer T; Yalcin S; Bozkaya D; Yiğit S; Tanyel FC
    J Perinatol; 2014 Oct; 34(10):800-1. PubMed ID: 25263728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
    Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
    Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side-effects of long-term prostaglandin E(1) treatment in neonates.
    Tálosi G; Katona M; Túri S
    Pediatr Int; 2007 Jun; 49(3):335-40. PubMed ID: 17532831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic gastritis with gastric outlet obstruction mimicking infantile hypertrophic pyloric stenosis.
    Choi SJ; Jang YJ; Choe BH; Cho SH; Ryeom H; Hong SJ; Lee D
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):e9-e11. PubMed ID: 25222812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.